News and Press Releases

Contact Veristat Now


Request A Proposal

Contact Us

Veristat Expands Its Clinical Operations into Europe - Acquires UK-based CRO, Spero Oncology

May 1, 2016

SOUTHBOROUGH, MA – May 2, 2016Veristat, a full service Clinical Research Organization (CRO), announced today that it is expanding its clinical research offerings into Europe through the acquisition of UK-based CRO, Spero Oncology.   Spero Oncology is a UK-based CRO specializing in providing clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand. With the acquisition of Spero Oncology, Veristat now offers its clients full clinical operations support in Europe including feasibility studies, legal representation in the European Union, Clinical Monitoring, Project Management, Protocol Writing and Regulatory Strategy.

Read More